GlassScriptPhysician profile
Mary Hoang
NPI 1043623937
$1,520.64
in general payments reported to CMS, 2019-2025
13 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2021: $193 · 2022: $212 · 2023: $141 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $355.90 | 2019 | |
| Allergan, INC. | $210.03 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $163.60 | 2025 | Acthar |
| Johnson & Johnson Vision Care, INC. | $136.69 | 2019 | |
| Genentech USA, INC. | $131.70 | 2025 | Susvimo |
| Horizon Therapeutics Plc | $114.95 | 2022 | |
| Carl Zeiss Meditec, INC. | $113.33 | 2019 | |
| Apellis Pharmaceuticals, INC. | $101.38 | 2023 | Syfovre |
| Novartis Pharmaceuticals Corporation | $79.84 | 2021 | |
| Alcon Vision LLC | $45.19 | 2023-2025 | Total30, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $34.32 | 2025 | Xdemvy |
| Glaukos Corporation | $18.98 | 2025 | Idosetr, Istent Infinite |
| Sight Sciences, INC. | $14.73 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.